Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancer.

Wiser I, Orr N, Kaufman B, Segev S, Smetana Z, Bialik A, Epstein N, Mendelson E, Catane R, Cohen D.

J Infect Dis. 2010 May 15;201(10):1527-34. doi: 10.1086/651950.

PMID:
20388035
2.

The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.

Kim SH, Yeo SG, Park KH, Bang JW, Kim HB, Kim NJ, Jee Y, Cho H, Oh MD, Choe KW.

Clin Microbiol Infect. 2007 Jan;13(1):91-3.

3.

Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations.

Hatakeyama S, Moriya K, Saijo M, Morisawa Y, Kurane I, Koike K, Kimura S, Morikawa S.

Clin Diagn Lab Immunol. 2005 Apr;12(4):520-4.

4.

Dose-related effects of smallpox vaccine.

Frey SE, Newman FK, Cruz J, Shelton WB, Tennant JM, Polach T, Rothman AL, Kennedy JS, Wolff M, Belshe RB, Ennis FA.

N Engl J Med. 2002 Apr 25;346(17):1275-80. Epub 2002 Mar 28.

5.

Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.

Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.

J Virol. 2008 Apr;82(7):3517-29. doi: 10.1128/JVI.01854-07. Epub 2008 Jan 16.

6.

Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.

Somekh E, Smetana Z, Tanay A, Dalal I, Babai I, Mendelson E.

Vaccine. 2004 Dec 2;23(3):321-4.

PMID:
15530675
7.

Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.

Pittman PR, Garman PM, Kim SH, Schmader TJ, Nieding WJ, Pike JG, Knight R, Johnston SC, Huggins JW, Kortepeter MG, Korman L, Ranadive M, Quinn X, Meyers MS.

Vaccine. 2015 Jun 12;33(26):2990-6. doi: 10.1016/j.vaccine.2015.04.062. Epub 2015 Apr 27.

PMID:
25930115
8.

Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.

Trojan A, Rajeswaran R, Montemurro M, Mütsch M, Steffen R.

J Clin Virol. 2007 Sep;40(1):80-3. Epub 2007 Jul 20.

PMID:
17644471
9.

Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.

Kennedy JS, Frey SE, Yan L, Rothman AL, Cruz J, Newman FK, Orphin L, Belshe RB, Ennis FA.

J Infect Dis. 2004 Oct 1;190(7):1286-94. Epub 2004 Aug 30.

PMID:
15346340
10.

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.

Paran N, Suezer Y, Lustig S, Israely T, Schwantes A, Melamed S, Katz L, Preuss T, Hanschmann KM, Kalinke U, Erez N, Levin R, Velan B, Löwer J, Shafferman A, Sutter G.

J Infect Dis. 2009 Jan 1;199(1):39-48. doi: 10.1086/595565.

PMID:
19012492
11.

Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.

Treanor J, Wu H, Liang H, Topham DJ.

Vaccine. 2006 Nov 17;24(47-48):6913-23. Epub 2006 Jun 21.

PMID:
17014939
12.

Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.

Hsieh SM, Chen SY, Sheu GC, Hung MN, Chou WH, Chang SC, Hsu KH.

Vaccine. 2006 Jan 23;24(4):510-5. Epub 2005 Aug 18.

PMID:
16139395
13.

Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.

Ennis FA, Cruz J, Demkowicz WE Jr, Rothman AL, McClain DJ.

J Infect Dis. 2002 Jun 1;185(11):1657-9. Epub 2002 May 17.

PMID:
12023773
14.

A novel, killed-virus nasal vaccinia virus vaccine.

Bielinska AU, Chepurnov AA, Landers JJ, Janczak KW, Chepurnova TS, Luker GD, Baker JR Jr.

Clin Vaccine Immunol. 2008 Feb;15(2):348-58. Epub 2007 Dec 5.

15.

Bioterrorism. Smallpox vaccinations: how much protection remains?

Cohen J.

Science. 2001 Nov 2;294(5544):985. No abstract available.

PMID:
11691969
16.

Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus.

Kim SH, Bang JW, Park KH, Park WB, Kim HB, Kim NJ, Jee Y, Cho H, Oh MD, Choe KW.

J Infect Dis. 2006 Aug 1;194(3):377-84. Epub 2006 Jun 30. Erratum in: J Infect Dis. 2007 May 15;195(10):1552.

PMID:
16826487
17.

Immunity from smallpox vaccine persists for decades: a longitudinal study.

Taub DD, Ershler WB, Janowski M, Artz A, Key ML, McKelvey J, Muller D, Moss B, Ferrucci L, Duffey PL, Longo DL.

Am J Med. 2008 Dec;121(12):1058-64. doi: 10.1016/j.amjmed.2008.08.019.

18.

Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R.

J Immunol. 2003 Nov 15;171(10):4969-73.

19.

Monitoring of human immunological responses to vaccinia virus.

Harrop R, Ryan MG, Golding H, Redchenko I, Carroll MW.

Methods Mol Biol. 2004;269:243-66. Review.

PMID:
15114020
20.

Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection.

Kan VL, Manischewitz J, King LR, Golding H.

AIDS. 2007 Feb 19;21(4):521-4.

PMID:
17301573

Supplemental Content

Support Center